81 related articles for article (PubMed ID: 25641919)
1. Functional nature of a novel mutant CYLD observed in pediatric lymphoblastic B-cell leukemia.
Arora M; Kaul D; Varma N
Pediatr Blood Cancer; 2015 Jun; 62(6):1066-9. PubMed ID: 25641919
[TBL] [Abstract][Full Text] [Related]
2. Cellular proteolytic modification of tumor-suppressor CYLD is critical for the initiation of human T-cell acute lymphoblastic leukemia.
Arora M; Kaul D; Varma N; Marwaha RK
Blood Cells Mol Dis; 2015 Jan; 54(1):132-8. PubMed ID: 25130432
[TBL] [Abstract][Full Text] [Related]
3. Mutational analysis of DOK2 tumor suppressor gene in acute leukemias.
Kim MS; Chung NG; Yoo NJ; Lee SH
Leuk Res; 2011 Jun; 35(6):e87-8. PubMed ID: 21329978
[No Abstract] [Full Text] [Related]
4. CYLD Regulates Noscapine Activity in Acute Lymphoblastic Leukemia via a Microtubule-Dependent Mechanism.
Yang Y; Ran J; Sun L; Sun X; Luo Y; Yan B; Tala ; Liu M; Li D; Zhang L; Bao G; Zhou J
Theranostics; 2015; 5(7):656-66. PubMed ID: 25897332
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a leukemia cell line with i(12p) from a patient with a mediastinal germ cell tumor and acute lymphoblastic leukemia.
Downie PA; Vogelzang NJ; Moldwin RL; Le Beau MM; Anastasi J; Allen RJ; Myers SE; Larson RA; Smith SD
Cancer Res; 1994 Sep; 54(18):4999-5004. PubMed ID: 8069867
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of CYLD as a trigger for NF-κB activation and a mechanism of apoptotic resistance in hepatocellular carcinoma cells.
Urbanik T; Köhler BC; Boger RJ; Wörns MA; Heeger S; Otto G; Hövelmeyer N; Galle PR; Schuchmann M; Waisman A; Schulze-Bergkamen H
Int J Oncol; 2011 Jan; 38(1):121-31. PubMed ID: 21109933
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of cylindromatosis gene, CYLD, confers a growth advantage on malignant melanoma cells while negatively regulating their migration activity.
Ishikawa Y; Tsunoda K; Shibazaki M; Takahashi K; Akasaka T; Masuda T; Maesawa C
Int J Oncol; 2012 Jul; 41(1):53-60. PubMed ID: 22469839
[TBL] [Abstract][Full Text] [Related]
8. Mutated cylindromatosis gene affects the functional state of dendritic cells.
Bros M; Dexheimer N; Besche V; Masri J; Trojandt S; Hövelmeyer N; Reissig S; Massoumi R; Grabbe S; Waisman A; Reske-Kunz AB
Eur J Immunol; 2010 Oct; 40(10):2848-57. PubMed ID: 20836156
[TBL] [Abstract][Full Text] [Related]
9. The tumor suppressor CYLD controls the function of murine regulatory T cells.
Reissig S; Hövelmeyer N; Weigmann B; Nikolaev A; Kalt B; Wunderlich TF; Hahn M; Neurath MF; Waisman A
J Immunol; 2012 Nov; 189(10):4770-6. PubMed ID: 23066153
[TBL] [Abstract][Full Text] [Related]
10. A new partner gene fused to ABL1 in a t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia.
De Braekeleer E; Douet-Guilbert N; Le Bris MJ; Berthou C; Morel F; De Braekeleer M
Leukemia; 2007 Oct; 21(10):2220-1. PubMed ID: 17541395
[No Abstract] [Full Text] [Related]
11. A novel splicing mutation of the CYLD gene in a Taiwanese family with multiple familial trichoepithelioma.
Huang TM; Chao SC; Lee JY
Clin Exp Dermatol; 2009 Jan; 34(1):77-80. PubMed ID: 19076795
[TBL] [Abstract][Full Text] [Related]
12. Tumour suppressor CYLD is a negative regulator of the mitotic kinase Aurora-B.
Sun L; Gao J; Huo L; Sun X; Shi X; Liu M; Li D; Zhang C; Zhou J
J Pathol; 2010 Aug; 221(4):425-32. PubMed ID: 20593489
[TBL] [Abstract][Full Text] [Related]
13. Germline mutation of the p27/Kip1 gene in childhood acute lymphoblastic leukemia.
Takeuchi C; Takeuchi S; Ikezoe T; Bartram CR; Taguchi H; Koeffler HP
Leukemia; 2002 May; 16(5):956-8. PubMed ID: 11986963
[No Abstract] [Full Text] [Related]
14. Evidence for whole chromosome 6 loss and duplication of the remaining chromosome in acute lymphoblastic leukemia.
McEvoy CR; Morley AA; Firgaira FA
Genes Chromosomes Cancer; 2003 Jul; 37(3):321-5. PubMed ID: 12759931
[TBL] [Abstract][Full Text] [Related]
15. Thymocyte-specific truncation of the deubiquitinating domain of CYLD impairs positive selection in a NF-kappaB essential modulator-dependent manner.
Tsagaratou A; Trompouki E; Grammenoudi S; Kontoyiannis DL; Mosialos G
J Immunol; 2010 Aug; 185(4):2032-43. PubMed ID: 20644164
[TBL] [Abstract][Full Text] [Related]
16. Homozygous deletions of p16/MTS1 and p15/MTS2 genes are frequent in t(1;19)-negative but not in t(1;19)-positive B precursor acute lymphoblastic leukemia in childhood.
Ohnishi H; Hanada R; Horibe K; Hongo T; Kawamura M; Naritaka S; Bessho F; Yanagisawa M; Nobori T; Yamamori S; Hayashi Y
Leukemia; 1996 Jul; 10(7):1104-10. PubMed ID: 8683987
[TBL] [Abstract][Full Text] [Related]
17. Clinical and cytogenetic features of pediatric dic(9;20)(p13.2;q11.2)-positive B-cell precursor acute lymphoblastic leukemias: a Nordic series of 24 cases and review of the literature.
Forestier E; Gauffin F; Andersen MK; Autio K; Borgström G; Golovleva I; Gustafsson B; Heim S; Heinonen K; Heyman M; Hovland R; Johannsson JH; Kerndrup G; Rosenquist R; Schoumans J; Swolin B; Johansson B; Nordgren A; ; ;
Genes Chromosomes Cancer; 2008 Feb; 47(2):149-58. PubMed ID: 17990329
[TBL] [Abstract][Full Text] [Related]
18. Mutant PRPS1: a new therapeutic target in relapsed acute lymphoblastic leukemia.
Mullighan CG
Nat Med; 2015 Jun; 21(6):553-4. PubMed ID: 26046573
[No Abstract] [Full Text] [Related]
19. Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemia.
Verrills NM; Po'uha ST; Liu ML; Liaw TY; Larsen MR; Ivery MT; Marshall GM; Gunning PW; Kavallaris M
J Natl Cancer Inst; 2006 Oct; 98(19):1363-74. PubMed ID: 17018783
[TBL] [Abstract][Full Text] [Related]
20. Loss of CYLD might be associated with development of salivary gland tumors.
Fukuda M; Hiroi M; Suzuki S; Ohmori Y; Sakashita H
Oncol Rep; 2008 Jun; 19(6):1421-7. PubMed ID: 18497946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
